Search

everythinglearnresearchcommunity

for

Search:↓

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

3D-printed membranes with smart sensors can greatly improve tissue healing and have many medical applications.

The chitosan/PDRN polyplex improved wound healing in diabetic rats.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

More research is needed to understand how testosterone is maintained in adult males.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

Topical minoxidil showed promise for early male pattern baldness.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Finasteride worsens heart damage from nandrolone decanoate but protects against cell damage.

Methyl prednisolone helps most patients with alopecia universalis regrow hair.

The Persian cat has a skin infection caused by a fungus, treatable with antifungal medication.

Finasteride effectively treats hair loss in transgender men with few side effects.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.